Quantitative determination of cholesterol in liposome drug products and raw materials by high-performance liquid chromatography

Most liposomes used as drug delivery systems contain cholesterol as a majot structural component. Cholesterol has profound effects on the chemical, physical and metabolic stability of liposomes and lipsome drug products and must be accurately monitored during formulation and processing development,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Chromatography A 1990-05, Vol.507, p.157-163
Main Author: Lang, Johanna K.
Format: Article
Language:English
Subjects:
Analysis
Biological and medical sciences
General pharmacology
Medical sciences
Pharmacology. Drug treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Most liposomes used as drug delivery systems contain cholesterol as a majot structural component. Cholesterol has profound effects on the chemical, physical and metabolic stability of liposomes and lipsome drug products and must be accurately monitored during formulation and processing development, stability testing and manufacturing. Before analyzing their components, the liposomes must be disintegrated and solubilized by dilution with methanol or 2-propanol. This high-performance liquid chromatographic assay is applicable to the resulting lipid-rich matrices and allows a direct quantitative analysis of cholesterol. Cholesterol separates well from common ingredients of liposome-based drug products and cholesterol oxidation products. Calibration curves are linear over two order of magnitude and the cholesterol detection limit is 1.5 μl/ml. Method precision for an anticancer liposome drug formulation was 0.9% relative standard deviation. The assay is also useful for measuring cholesterol in phospholipid and cholesterol raw materials.
ISSN:0021-9673
DOI:10.1016/S0021-9673(01)84191-1